NCT02394340View on ClinicalTrials.gov

Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2015

Primary Completion Date

April 1, 2015

Study Completion Date

April 1, 2015

Conditions

Tinea PedisTinea Cruris

Interventions

DRUG

Omeprazole 40 mg

Oral capsule to be taken as per the instructions regarding proper dosing technique.

DRUG

Luliconazole Cream 1%

Topical cream to be applied as per the instructions regarding proper study drug application technique.

Trial Locations (1)

07410

TKL Research, Fair Lawn

All Listed Sponsors

collaborator

Bausch Health Americas, Inc.

INDUSTRY

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT02394340 - Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris | Biotech Hunter | Biotech Hunter